lamivudine has been researched along with Down Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clotet, B; Dierssen, M; Elizalde-Torrent, A; Martinez de Lagran, M; Paredes, R | 1 |
1 other study(ies) available for lamivudine and Down Syndrome
| Article | Year |
|---|---|
Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome.
Topics: Animals; Cognition; Disease Models, Animal; Down Syndrome; Lamivudine; Mice; Mice, Transgenic; Reverse Transcriptase Inhibitors | 2022 |